Evaluation of Effectiveness and Safety of Antegrade and Retrograde Approach of Percutaneous Coronary Intervention for Chronic Total Occlusions

NCT03667196 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2024-12-27

No results posted yet for this study

Summary

Objective of this study is to 1) analyze the clinical, anatomical and periprocedural differences of patients who underwent a procedure related to coronary CTO through the antergrade approach and retrograde approach; 2) analyze the success rate of the procedures and the incidence and patterns of complications; 3) compare and analyze long-term performances after the successful procedure; and 4) identify the independent factors that require a retrograde approach and the prognostic factor regarding long-term performances after use of each approach.

Conditions

  • Chronic Total Occlusion of Coronary Artery

Interventions

PROCEDURE

antegrade and retrograde approach

This study intends to identify and compare the clinical, anatomical and periprocedural factors of the patients who used only the antergrade approach and the patients who needed the retrograde approach among the patients with coronary CTO

Sponsors & Collaborators

  • Abbott Medical Devices

    collaborator INDUSTRY
  • Biotronik SE & Co. KG

    collaborator INDUSTRY
  • Medtronic

    collaborator INDUSTRY
  • Dio Medical

    collaborator UNKNOWN
  • Seung-Whan Lee, M.D., Ph.D.

    lead OTHER

Principal Investigators

  • Seung-Whan Lee, MD · Asan Medical Center

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-11
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03667196 on ClinicalTrials.gov